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ABSTRACT
Chromatin immunoprecipitation with massively par-
allel DNA sequencing (ChIP-seq) has greatly im-
proved the reliability with which transcription factor
binding sites (TFBSs) can be identified from genome-
wide profiling studies. Many computational tools are
developed to detect binding events or peaks, how-
ever the robust detection of weak binding events re-
mains a challenge for current peak calling tools. We
have developed a novel Bayesian approach (ChIP-
BIT) to reliably detect TFBSs and their target genes
by jointly modeling binding signal intensities and
binding locations of TFBSs. Specifically, a Gaussian
mixture model is used to capture both binding and
background signals in sample data. As a unique
feature of ChIP-BIT, background signals are mod-
eled by a local Gaussian distribution that is accu-
rately estimated from the input data. Extensive sim-
ulation studies showed a significantly improved per-
formance of ChIP-BIT in target gene prediction, par-
ticularly for detecting weak binding signals at gene
promoter regions. We applied ChIP-BIT to find tar-
get genes from NOTCH3 and PBX1 ChIP-seq data
acquired from MCF-7 breast cancer cells. TF knock-
down experiments have initially validated about 30%
of co-regulated target genes identified by ChIP-BIT as
being differentially expressed in MCF-7 cells. Func-
tional analysis on these genes further revealed the
existence of crosstalk between Notch and Wnt sig-
naling pathways.
INTRODUCTION
The advent of chromatin immunoprecipitation with mas-
sively parallel DNA sequencing (ChIP-seq) has dramati-
cally accelerated the field of genomic research in gaining an
in-depth understanding of complex functions of regulatory
elements in the finest scale (1). Recently, ChIP-seq profiling
of eukaryote cells has been used successfully to identify his-
tonemodifications (2), distal-acting enhancers (3) and prox-
imal transcription factor binding sites (TFBSs) at promoter
regions (4). With the TFBSs identified from ChIP-seq data,
it is now possible to reliably define target genes for specific
transcription factors (TFs) (5). If multiple ChIP-seq data
sets are available, researchers can investigate the extent of
co-association amongmultiple TFs based onTF-gene bind-
ing patterns (6). Hence, it is important to develop accurate
computational approaches for identifying binding sites and
target genes from ChIP-seq data (7).
Traditionally, target genes are predicted by using peak
calling methods and gene annotation tools. ChIP-seq peaks
can be detected or called using MACS (8), PeakSeq (9) or
other peak calling methods; peak-to-gene assignment tools
such as GREAT (10) can then be used to construct a binary
binding relationship with a predefined promoter region re-
lated to transcription starting site (TSS). Several computa-
tional tools have been proposed and developed to identify
target genes directly fromChIP-seq data. Ouyang et al. pro-
posed to use a weighted sum of ChIP-seq binding signals at
each gene’s promoter region for target gene identification
(11). In their method, the regulatory effect on gene tran-
scription (with respect to the relative location of TFBS to
TSS) was modeled by an exponential distribution function.
Cheng et al. proposed a probabilistic method (called TIP) to
address the same problem by constructing a joint distribu-
tion of ChIP-seq binding signals and their relative locations
to TSS (5). Chen et al. further improved the TIP method
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for target gene prediction by incorporating the significance
information of peaks (12). To investigate potential associa-
tion ofmultiple TFs,Giannopoulou et al. scored each called
peak based on its location at the promoter region of a tar-
get gene and further clustered DNA-binding proteins using
a non-negative matrix factorization method (6). Guo et al.
proposed a generative probabilistic model to discover TF-
gene binding events by integrating ChIP-seq data andDNA
motif information (13). Wong et al. proposed a hierarchical
model (in their SignalSpider tool) to learn TF clusters at
enhancer or gene promoter regions by using multiple nor-
malized ChIP-seq signal profiles (14).
Despite the initial success of these methods, most are de-
veloped based on available peaks by selecting highly sig-
nificant signals of sample ChIP-seq data when compared
with those of input data. Only TIP and SignalSpider con-
sider the contribution of weak signals in sample ChIP-seq
data. However, reliable identification of weak binding sig-
nals from background signals (i.e. non-specific binding sig-
nals) is a challenging task itself, since it requires a high se-
quencing depth of both sample and input ChIP-seq data
sets (15). If the sequencing depth is not sufficient, existing
peak detection methods return a high rate of false positives
in the so-called weak binding signals. The high false positive
rate makes the use of weak binding signals unreliable and
impractical in such tools as TIP and SignalSpider. To reduce
the false positive rate, we have proposed a novel probabilis-
tic approach for TFBS and target gene identification where:
(i) sample and input ChIP-seq data are jointly analyzed to
reliably identify weak binding signals; (ii) the effect of TFBS
on downstream gene transcription is also incorporated. Our
proposed approach takes into account three major factors
that determine the possibility of a proximal region contain-
ing a TF binding event: sample read intensity, input read in-
tensity and relative distance of the TFBS to its TSS (16).We
jointly model these three factors within a Bayesian frame-
work, ChIP-BIT (Bayesian Inference of Target genes using
ChIP-seq profiles).
The basic idea of the ChIP-BIT approach can be briefly
described to highlight its novelty and uniqueness. ChIP-BIT
uses a Gaussian mixture model (consisting of global and
local Gaussian components) to capture both binding and
background signals in the sample data. A unique feature
is that the Gaussian component modeling background sig-
nals is specially designed as a local Gaussian distribution
that can be estimated accurately from the input data. An
exponential distribution is used to model the relative dis-
tance of TFBS to TSS, which is further incorporated into
the Bayesian approach of ChIP-BIT for target gene infer-
ence. Estimated by an expectation-maximization (EM) al-
gorithm, a posterior probability is assigned to each TFBS
under consideration, indicating the likelihood of a TF-gene
binding event. While genes co-regulated by a pair of TFs
can be predicted using themethods introduced in (6,14), the
negative impact of false positive peaks in weak binding sig-
nals cannot be ignored. For a pair of associated TFs, ChIP-
BIT estimates a co-regulation probability for each common
target gene based on the probabilities of individual binding
events and their relative distance at promoter region.
To demonstrate the capability of ChIP-BIT on TFBS de-
tection and target gene identification, we have applied it to
Figure 1. Flowchart of the proposed ChIP-BIT approach. ChIP-BIT fea-
tures (i) a joint analysis of sample and input ChIP-seq data with a unique
Gaussian mixture model for transcription factor binding site (TFBS) iden-
tification, and (ii) a Bayesian framework to incorporate the location infor-
mation of TFBS for target gene identification.
several simulated or real ChIP-seq data sets with known
or validated binding peaks at promoter regions, and com-
pared its performance with several existing peak detection
and gene prediction methods. For TF co-regulation iden-
tification, we have further tested ChIP-BIT on a large-scale
data set consisting of over 100ChIP-seq profiles of leukemia
K562 cell line obtained from the ENCODE project (17). Fi-
nally, we have applied ChIP-BIT to an in-house ChIP-seq
profiling study focused on NOTCH3 and PBX1 to help un-
derstand their functional roles in breast cancer cells. The
effect of NOTCH3 and PBX1 co-regulation on target genes
was investigated in conjunction with TF knockdown gene
expression data. Our analysis of ChIP-seq data showed that
NOTCH3 and PBX1 are also involved in the regulation of
Wnt signaling pathway, indicating that crosstalk may exist
between the Notch and Wnt signaling pathways.
MATERIALS AND METHODS
Workflow of the proposed approach
The workflow of the proposal approach is illustrated in Fig-
ure 1. Sample ChIP-seq data and its matched input are
jointly analyzed in this framework such that a majority
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of mappability and GC content biases could be resolved.
We first search for genomic regions with read coverage in
a TF-DNA binding profile (sample ChIP-seq data) by us-
ing uniquely aligned ChIP-seq reads. After accommodating
genomemappability variation, filtering out regions contain-
ing low read coverage and normalizing the control bind-
ing profile (input ChIP-seq data) against the sample data,
we identify an initial set of candidate genomic regions. We
then performpromoter region partition based on theUCSC
hg19 RefSeq file, map candidate regions to small windows
each with a size of 200 base pairs (bps), and calculate read
intensities of sample and input data, respectively, in each
window. Major steps of ChIP-seq data preprocessing are
described in Supplementary Material S1, as shown in Sup-
plementary Figures S1 and S2.
The proposed ChIP-BIT method is then used to com-
pute a posterior probability for each window in order to
call whether or not a window contains TFBS. Specifically,
ChIP-BIT jointly analyzes sample read intensity and in-
put read intensity using a Bayesian framework. Under the
Bayesian framework, ChIP-BIT models the sample read
intensity with a Gaussian mixture model, consisting of a
global Gaussian component for binding signals and a local
Gaussian component for background signals. Importantly,
the local Gaussian component can be accurately estimated
from the input read intensity, making it possible to detect
weak binding signals reliably because of the lower false pos-
itive rate. The relative distance of TFBS to TSS is modeled
by an exponential distribution function and incorporated
into the Bayesian approach of ChIP-BIT for target gene in-
ference. An EM algorithm estimates a posterior probability
that each window contains a true TFBS for target gene reg-
ulation. Windows with posterior probabilities over a pre-
defined probability threshold are merged together if they
are continuous. The merged windows are finally reported as
TFBSs for potential binding events to occur, and their as-
sociated target genes are also reported accordingly. In Sup-
plementary Material S2, an overall workflow of the ChIP-
BIT implementation is shown in Supplementary Figure S3;
the formats of its input and output files are summarized in
Supplementary Table S1. Additionally for core functions of
ChIP-BIT, an example including input and output signals
is shown in Supplementary Figure S4.
Model description of ChIP-BIT
We define the scale of promoter region as ±10k bps from
the TSS (5) and divide each promoter region into small
non-overlapping windows. For ChIP-seq data analysis, the
window-based approach has been used in several peak
detection methods including SICER (18), BCP (19) and
HOMER (20). To use a standard way to incorporate the in-
formation of relative distance to the TSS, we choose a win-
dow size of 200 bps to define a basic window unit, whose
midpoint to TSS is defined as the relative distance for all
binding signals falling in this window. We map candidate
enriched regions to windows and use read intensity s, the
natural log of the read coverage, to represent the read en-
richment status in each window, as shown in Figure 2.
ChIP-seq data can be treated as a mixture of TFBSs
and background signals. Background signals are fully rep-
resented in the input data, but TFBSs need to be distin-
guished frombackground signals in the sample data.Hence,
each enriched region has two hidden states: binding occur-
rence b = 1 and non-occurrence b = 0, with probabilities
a1 and a0, respectively. The sum of these two probabilities
equals to 1. If a1 > a0, this region is more likely to contain
a TFBS, shown as a ‘red’ bar in Figure 2; otherwise, it is a
background region, shown as a ‘blue’ bar in Figure 2. Read
intensity is a major signature to help identify TFBS. The
value of read intensity s in the sample data (‘red’ or ‘blue’
bars) and its differentiation against sinput from the input
data (‘gray’ bars) altogether determine whether or not this
binding event truly occurs. The regulatory effect of peaks on
target gene transcription also must be considered for TFBS
prediction. This effect is mainly reflected by the relative dis-
tance d of s to its nearest TSS. The shorter d is, the more
possible s is sampled from an effective TFBS, shown as the
‘red’ curve in Figure 2. However, if s comes from a back-
ground region, no matter where it is located, its contribu-
tion to gene regulation is non-informative (the ‘blue’ curve
in Figure 2). We have developed a probabilistic approach
using a Bayesian framework to achieve TFBS detection and
target gene identification simultaneously.
Bayesian framework for TFBS and target gene prediction
We use n to index target genes and w to index windows at
the n-th gene promoter region. The binding variable bn,w
has two hidden states as binding occurrence (bn,w = 1) and
non-binding occurrence (bn,w = 0). Each binding variable
(bn,w) has three observations as read intensity sn,w in the
sample data, read intensity sn,w,input in the input data, and
binding location information dn,w (referring to as the rela-
tive distance to TSS). For each bn,w = 1 or 0, we define a
posterior probability an,w,ias:
an,w,i = P(bn,w = i
∣∣ sn,w, dn,w), i = 0, 1. (1)
Given an enriched window, the relationship between its
binding signal intensity and relative distance to TSS is as-
sumed to be conditionally independent. Then, Equation (1)
can be extended as:
an,w,i= 1Cn,w P(sn,w|bn,w=i )P(dn,w|bn,w=i )P(bn,w=i ), (2)
where Cn,w =
∑
bn,w=0,1
P(sn,w, dn,w|bn,w)P(bn,w) is a normal-
ization factor.
Based on the available literature and real data examina-
tions, read intensity sn,w follows a mixture Gaussian distri-
bution (14), as P(sn,w|bn,w = 1) and P(sn,w|bn,w = 0) in Fig-
ure 2.More details about how to calculate read intensity can
be found in SupplementaryMaterial S3 (see Supplementary
Figure S5 for an illustration and Supplementary Figure S6
for an example). The conditional probability P(sn,w|bn,w) in
Equation (2) can be calculated as:{
P(sn,w|bn,w = 1) ∼ N(μTFBS, σ 2TFBS),
P(sn,w|bn,w = 0) ∼ N(sn,w,input, σ 2input). (3)
where for bn,w = 1, sn,w is sequenced from a TFBS so it
follows a global Gaussian distribution with mean μTFBS
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Figure 2. Model description of ChIP-BIT on TFBS detection and target gene identification. A ‘red’ bar represents the read intensity of a TFBS and a ‘blue’
bar represents the read intensity of a background region. Those ‘gray’ bars represent input signals at the same locations of any ‘red’ or ‘blue’ bars. For
each window, read intensities from sample and input data are jointly analyzed for reliable TFBS identification; relative distance to (transcription starting
site) TSS is also considered in a Bayesian framework for target gene prediction.
and variance σ 2TFBS; while for bn,w = 0, sn,w is sequenced
from background region so it follows a local Gaussian dis-
tribution with mean sn,w,input (its input signal) and variance
σ 2input. σ
2
input is the variance of background signals, which
can be directly calculated from the input data. The values
of μTFBS and σ 2TFBS are both unknown and need to be esti-
mated from all sn,w with state bn,w = 1.
The second conditional probability in (2), P(dn,w|bn,w),
is determined by the relative distance dn,w to TSS as well as
the binding state bn,w. dn,w is defined as the distance between
middle point of the w-th window to TSS of n-th gene.
dn,w = (w + sign(w) ∗ 12)d, (4)
where d denotes window size, and w =
{0,±1,±2, ...,±(W− 1)}. The total number of win-
dows at one side of promoter, W, is defined by dp/d. dp
represents the length of half promoter region (positive side
or negative side to TSS). We set d = 200 bps and dp =
10k bps for all the experiments conducted in this paper.
The regulatory effect of a TFBS on its target gene de-
cays exponentially when dn,w increases (6,7,11,21,22). This
decaying effect is TF specific (11) and the parameter of
its exponential distribution needs to be properly optimized
so as to provide the most reliable gene prediction perfor-
mance (6) (which has been demonstrated to be better than
binary peak-gene assignment (7)). We have examined this
feature in real ChIP-seq data of TFs under different condi-
tions using similar ways as in (21,22) (Supplementary Ma-
terial S3). From Supplementary Figures S7 and S8, it can
be clearly seen that the average read enrichment in sam-
ple ChIP-seq data follows an exponential distribution along
gene promoter region while this distribution in input ChIP-
seq data is relatively uniform. When dn,w is very large, the
read enrichment of ChIP-seq binding is much lower than
that at proximal regions. Since different TFs may have dif-
ferent features on their binding signal location distributions
at promoter region, a parameter λ is introduced as shown
in Equation (5):{
P(dn,w|bn,w = 1) = e−λ|w|d (1 − e−λd )/2,
P(dn,w|bn,w = 0) = d/(2 ∗ dp). (5)
Parameter λ needs to be estimated from all dn,w with
bn,w = 1. Detailed derivation of Equation (5) can be found
in Supplementary Material S4 and Supplementary Figure
S9. For bn,w = 0, sn,w is treated as background signal so
that P(dn,w|bn,w = 0) is assumed to follow a uniform distri-
bution with a discrete probability density function d/(2 ∗
dp).
For the prior probability P(bn,w) in Equation (2), since
there is no prior knowledge about the proportion of regions
that containing TFBSs, we define the prior probability as
P(bn,w) = πbn,w (1 − π )(1−bn,w). (6)
From the above discussion, we have formulated the TFBS
detection problem as a parameter estimation problem: how
to estimate parameters π , μTFBS, σ 2TFBS and λ hence to cal-
culate the posterior probability an,w,1. We assume uniform
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prior on μTFBS, uniform prior on λ, inverse Gamma prior
on σ 2TFBS (conjugate prior of Gaussian distribution) and
Beta prior on π (conjugate prior of Binomial distribution)
as follows (23):
P(μTFBS) = 1/Cμ, (7)
P(λ) = 1/Cλ, (8)
P(σ 2TFBS) = inverseGamma(α, β), (9)
P(π ) = Beta(β0, β1), (10)
where α and β are hyper-parameters for inverseGammadis-
tribution and β0 and β1 are hyper-parameters for Beta dis-
tribution.
We assume inverse Gamma distribution on variance
σ 2TFBS because wewant to limitmost binding signals around
μTFBS. This is consistent with the ChIP-seq data genera-
tion process, since most segments selected (‘picked up’) by
the antibody are sequenced to a similar depth. Some back-
ground regions are also sequenced by the machine but, due
to the lack of antibody selection, their sequence depth is
lower than binding regions. In addition, after read tag as-
sembly, there are usually some segments showing extremely
high coverage. As demonstrated in (24), these regions are
mainly caused by segment duplication (high copy number),
not TF-specific binding locations. Therefore, we assume an
inverse Gamma distribution on σ 2TFBS to lower the impact
of noise on TFBS binding signal distribution estimation.
To estimate the parameters described above, we define a
second posterior probability as
P(π,μTFBS, σ 2TFBS, λ
∣∣ s, d)
= 1
C1
∏
n
∏
w
P( sn,w, dn,w
∣∣μTFBS, σ 2TFBS, λ, π) 1Cμ
1
Cλ
P(π) · P(σ 2TFBS),
= 1
C2
∏
n
∏
w
∑
bn,w=0,1
[
P(sn,w |bn,w)P(dn,w |bn,w)P(bn,w)
] · P(π) · P(σ 2TFBS)
(11)
where C1 and C2 = C1CμCλ are constant values.
Within this Bayesian framework, we can estimate all pa-
rameters (π , μTFBS, σ 2TFBS and λ) and the posterior proba-
bility (an,w,1) using an EM approach. We set the initial val-
ues of all an,w,1 to 0.5, beta distribution parameters β0 and
β1 to 5.0, and inverse gamma distribution parameters α and
β to 1.0. Then, we carry out the E-step and the M-step it-
eratively to estimate all parameters until the improvement
of the posterior probability defined in Equation (11) is less
than 1.0e-6. The E-step and M-step are mathematically de-
tailed as follows:
E-step:
aˆn,w,1 = P(sn,w |bn,w = 1)P(dn,w |bn,w = 1)π∑
bn,w=0,1
P(sn,w |bn,w)P(dn,w |bn,w)πbn,w (1 − π)(1−bn,w )
. (12)
M-step:
π =
∑
n
∑
w
aˆn,w,1 + (β1 − 1)
T + β0 + β1 − 2 , (13)
μTFBS =
∑
n
∑
w
aˆn,w,1sn,w
/∑
n
∑
w
aˆn,w,1, (14)
σ 2TFBS =
2β +∑
n
∑
w
aˆn,w,1(sn,w − μTFBS)2
(2α + 2 +∑
n
∑
w
aˆn,w,1)
, (15)
λ = 1
d
ln
⎛
⎝
∑
n
∑
w
aˆn,w,1 +
∑
n
∑
w
aˆn,w,1 |w|∑
n
∑
w
aˆn,w,1 |w|
⎞
⎠ . (16)
Based on our experiments on several ChIP-seq data sets,
iteration of the E-step and the M-step usually converges
within 50 rounds.More detailed deviation about the estima-
tion of each parameter in Equations (12–16) can be found
in Supplementary Material S5. For ChIP-seq data analysis,
we select as high confident binding events those windows
whose probabilities are over 0.9. Since each binding event
has been associated with a target gene, we obtain a target
gene list as identified for a particular TF under investiga-
tion.
CO-REGULATED TARGET GENE PREDICTION
For a pair of TFs of interest, based on the results of ChIP-
BIT, we can also calculate the probability for each common
target gene to reveal the two TFs’ co-regulatory effect on
gene transcription. After processing the ChIP-seq data for
each TF using ChIP-BIT, we extract all enriched windows
whose probabilities are larger than a threshold of 0.5. For
each gene, if multiple windows are enriched at it promoter
region, we select the window with the highest probability to
denote both binding location and binding confidence. We
define a variable cn,k, j with two states as co-regulation oc-
currence (cn,k, j = 1) and non-occurrence (cn,k, j = 0) for k-th
TF and j -th TF at the promoter region of n-th target gene.
Then, the posterior probability for cn,k, j is defined by
P(cn,k, j , bn,wk, bn,w j
∣∣ sn,wk, dn,wk, sn,w j , dn,w j )
= P(cn,k, j
∣∣ bn,wk, bn,w j , sn,wk, dn,wk, sn,w j , dn,w j )
P(bn,wk, bn,w j
∣∣ sn,wk, dn,wk, sn,w j , dn,w j )
= P(cn,k, j
∣∣ bn,wk, bn,w j , dn,wk, dn,w j )
P(bn,wk
∣∣ sn,wk, dn,wk)P(bn,w j ∣∣ sn,w j , dn,w j )
(17)
wherewk andw j denote window indices of k-th TF and j -th
TF, respectively. Candidate states for cn,k, j , bn,wk , bn,w j are
(1,1,1), (0,1,0), (0,0,1) and (0,0,0). Alternatively, these are
two states: bn,wkbn,w j = 1 and bn,wkbn,w j = 0.
The conditional probability
P(ck, j
∣∣ bn,wk, bn,w j , dn,wk, dn,w j ) with state cn,k, j , bn,wk, bn,w j
(1,1,1) depends on the relative distance of two binding
sites in the same gene’s promoter region. If these binding
sites are proximal, e.g. within 1k bps, the likelihood for
co-regulation occurrence will be high. If these sites are
located distantly, their co-regulation likelihood will be low.
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For all other states with bn,wkbn,w j = 0, no co-regulation
event occurs; hence, this likelihood function is not de-
pendent on any distance information. We assume an
exponential distribution f (bn,wkbn,w j = 1) for the likeli-
hood with state bn,wkbn,w j = 1, and an uniform distribution
f (bn,wkbn,w j = 0) for the likelihood with state bn,wkbn,w j =
0 as in the following equation:{
f (bn,wkbn,w j=1)=e−|wk−w j |d
/
d0 (1 − e−d/d0 )/2
f (bn,wkbn,w j=0)=d/(2 ∗ dp)
, (18)
where d0 is an effective region parameter that is set to 1k
bps.
Probability P(bn,wk
∣∣ sn,wk, dn,wk) (or P(bn,w j ∣∣ sn,w j , dn,w j ))
represents the posterior probability for each binding event
of k-th TF (or j -th TF), which can be estimated as aˆn,wk,1
(or aˆn,w j ,1) using Equation (12).With these two probabilities
and with f (bn,wkbn,w j ) incorporated into Equation (17), the
co-regulation probability with state cn,k, j , bn,wk, bn,w j (1,1,1)
can be calculated as follows:
P(cn,k, j=1, bn,wk=1, bn,w j=1
∣∣ sn,wk, dn,wk, sn,w j , dn,w j )
= f (bn,wkbn,w j =1)aˆn,wk,1aˆn,w j ,1∑
i=0,1
f (bn,wkbn,w j =i )(aˆn,wk,1aˆn,w j ,1)i (1−aˆn,wk,1aˆn,w j ,1)(1−i )
. (19)
Consequently, common target genes co-regulated by both
TFs can be ranked according to the posterior probability
calculated in Equation (19).
RESULTS
To demonstrate the effectiveness of ChIP-BIT on TFBS (or
peak) and target gene prediction, we tested ChIP-BIT on
simulated and experimental ChIP-Seq data sets and com-
pared the results with several available peak-calling meth-
ods including MACS, PeakSeq, BCP, Dfilter and MO-
SAiCS. MACS (8) and PeakSeq (9) are the two most widely
used peak calling methods; these tools use local Poisson or
Binomial statistics to identify enriched peaks. BCP (19) uses
a Bayesian change point approach to model read coverage
change along the genome and identifies peak boundaries.
Dfilter (25) calculates the form of an optimal detection fil-
ter with reads from input data and then applies this filter to
reads from sample data for peak prediction.MOSAiCS (26)
uses a negative binomial mixture model to identify enriched
windows based on read counts from sample and input data.
The detailed parameters used to run each tool can be found
in Supplementary Material S6.
Performance evaluation by realistic simulation studies
We generated a list of realistic genomic regions by apply-
ing PeakSeq (9) to MYC ChIP-seq data acquired from
a leukemia study of cell line K562 in the ENCODE
project (http://genome.ucsc.edu/ENCODE/). We selected
those peaks falling on chromosome 1 and mapped them to
the UCSC hg19 RefSeq file. Consistent with our model de-
sign, we set the promoter region as ±10k bps around TSS
for this simulation study. We observed an exponential-like
distribution of the relative distances of these peaks to the
TSS. Then, about 6000 proximal peaks in promoter regions
were extracted for simulation data generation.We randomly
selected half of the peaks as ‘true’ peaks and treated the re-
maining regions as ‘background’. Using a simulation tool
developed in (27), we simulated sample data and input data
with the same total number of reads (denoted as Case 1).
Read intensities of peaks or background regions and their
relative distance TSS can be found in Supplementary Ma-
terial S7, Supplementary Figure S10A and C. We called
peaks by using ChIP-BIT and other comparable peak call-
ing tools; a successful call is counted if a detected peak
overlaps with any ‘true’ peak in the promoter region. The
precision/recall performances of ChIP-BIT and other com-
peting methods on peak detection are shown in Figure 3.
Note that the denominator used in the precision calculation
is the number of peaks within the promoter regions. From
Figure 3A, we can see that the precision/recall performance
of ChIP-BIT is the best in Case 1, where the joint model of
sample and input data and informative distance distribution
significantly promote the precision of ChIP-BIT. As shown
in Figure 3B, ChIP-BIT has a strong detection capability on
weak binding signals (whose read intensity are lower than
the mean value of read intensities in sample data), which
promotes the overall performance of ChIP-BIT. Read in-
tensities and relative distances to TSS of peaks detected
by ChIP-BIT can be found in Supplementary Material S7,
Supplementary Figure S10B and D.
To show that ChIP-BIT still works well when the relative
distance distribution is more uniform (rather than exponen-
tial) along the promoter region, we simulated another pair
of data sets (denoted as Case 2) based on genomic regions
enriched in our in-house NOTCH3 ChIP-seq data acquired
fromMCF-7 breast cancer cells. In Case 2, when the distri-
bution of peaks along the promoter region is more uniform
and the read intensity difference between TFBSs and back-
ground regions is smaller (SupplementaryMaterial S7, Sup-
plementary Figure S11), the overall detection performance
of ChIP-BIT on simulated peaks in promoter regions is still
better than competingmethods, as shown in Figure 3C. The
performance improvement in Case 2 mainly reflects joint
modeling of read intensities from the sample and input data.
The Gaussian mixture model has enabled ChIP-BIT to de-
tect more weak binding signals at promoter regions than
any other existing method, as clearly shown in Figure 3D.
F-measure was calculated as
2*precision*recall/(precision+recall) to assess the overall
performance of each method, as summarized in Table 1
for all the methods in comparison. From Figure 3A–D
and Table 1, it can be seen that the detection performance
of ChIP-BIT on simulated peaks in the gene promoter
region is better than existing peak callers, especially in
terms of its detection performance on weak binding
signals. In Figure 3E and F, we further present the false
positive rate of weak binding signals as detected by each
method, when the overall precision (precision on all peaks)
is fixed at the same level (in a range of 0.70–0.95) for all
the methods in comparison. From the figures, we can
clearly see that ChIP-BIT has the lowest false positive rate
on the detected weak binding signals, a major benefit of
ChIP-BIT’s joint modeling of the sample and input data.
We also calculated the F-measure of each peak caller under
default or recommended settings for TF peak detection,
as shown in Supplementary Material S7, Supplementary
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Figure 3. Precision and recall performance of ChIP-BIT and existing peak calling methods on simulated ChIP-seq data. (A) Detection performance on all
peaks in simulation Case 1; (B) detection performance on weak binding signals in simulation Case 1; (C) detection performance on all peaks in simulation
Case 2; (D) detection performance on weak binding signals in simulation Case 2; (E) false positive rate of the detected weak binding signals in simulation
Case 1; (F) false positive rate of the detected weak binding signals in simulation Case 2.
 at Im
perial College London on A
pril 29, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
e65 Nucleic Acids Research, 2016, Vol. 44, No. 7 PAGE 8 OF 15
Tables S2 and S3. It can be found that ChIP-BIT achieves
the highest performance in both cases. Consequently, in
this stimulation study, the ability of ChIP-BIT in differing
binding sites from background regions at gene promoter
region is better than other competing methods, resulting in
an improved performance of ChIP-BIT.
Accuracy of the peak boundary detection for those cor-
rectly called peaks (denoted by the overlap proportion be-
tween detected peaks and ground truth) also must be eval-
uated. ChIP-BIT does not emphasize boundary detection,
due to its use of a window based genome partition, but how
much it covers background regions (precision) or cuts off
binding effective regions (recall) needs to be quantitatively
evaluated.We summarized the performance of peak bound-
ary detection for differentmethods in SupplementaryMate-
rial S7, Supplementary Tables S4 and S5. The highest preci-
sion value of ChIP-BIT demonstrated its capability to iden-
tify sharp peaks. The recall performance of ChIP-BIT was
mainly caused by the low read intensity at peak boundaries.
The other methods, except for PeakSeq, reported a high re-
call value but a much lower precision, indicating that they
captured some background regions close to the binding site.
The overall peak length distributions of ‘true’ peaks and
peaks called by each method are shown in Supplementary
Material S7, Supplementary Figures S12 and S13. It can
be found that most of the true peaks are quite sharp with
length smaller than 500 bps. ChIP-BIT and PeakSeq pro-
vided similar peak length distributions to that of the true
peaks, while peak length distributions of the other methods
had an overall shift to the ‘wide’ region.
Finally, we compared the performance of ChIP-BIT for
target gene prediction with that of method as proposed
by Ouyang et al. (11), TIP as proposed in (5) and its im-
proved version as proposed in (12). In the previous simu-
lation study of ChIP-BIT, we set the candidate promoter
region as ±10k bps from TSS. However, the true promoter
region might be closer to TSS, e.g. ±5k bps, ±2k bps or
even less. In real data analysis, it has been noted that dif-
ferent promoter regions may provide different results for
target gene prediction (5,10). To evaluate the performance
for different promoter regions, we therefore generated an-
other two simulation cases for either Case 1 or 2 with ‘true’
peaks within ±5k bps or ±2k bps promoter from the TSS,
respectively (in addition to the simulation data of±10k bps
promoter region). We applied ChIP-BIT, method proposed
by Ouyang et al., TIP and improved TIP to each data set
for target gene prediction. The area under the ROC curve
(AUC) values are summarized in Table 2. As shown in Sup-
plementary Material S7, Supplementary Figure S14, the
performance of method proposed by Ouyang et al. is sen-
sitive to the speed of its exponential decaying weight func-
tion. Thus, we tested multiple values of exponential decay-
ing speed and presented the best performance in Table 2.
ChIP-BIT outperformed the three peer methods. Interest-
ingly, in Case 1 the performance of TIP or its improved ver-
sion increases when the region of true binding signals gets
closer to the TSS, but their performance degrades in Case
2. After detailed examination, we found that in Case 1 the
location-specific weight distribution learned by TIP has a
sharp peak around TSS, as shown in Supplementary Ma-
terial S7, Supplementary Figure S15A and B. Therefore, if
‘true’ TFBSs are located close to the TSS, TIP can predict
target genemore accurately. However, in Case 2 binding sig-
nals are spread across all promoter regions more evenly. In
this case, the location-specific weight learned by TIP is more
uniformly distributed along the promoter region, as shown
in SupplementaryMaterial S7, Supplementary Figure S15C
and D. If ‘true’ binding sites are located very close to the
TSS, such as within±2k bps, and TIP is used to predict tar-
get genes, the contamination of background signals distant
to TSS will be significant because the sum of weight within
±2k bps is not significantly higher than that from ±2k bps
to±10k bps. In real genomic studies, there is often no prior
knowledge of the binding signal distribution around TSS,
and knowledge of the length of promoter regions is also
limited. Under such practical conditions, ChIP-BIT would
have a more robust performance for target gene identifica-
tion than the other existing methods.
Performance comparison using real ChIP-seq data
It is a challenging task to validate a large number of TFBSs
identified from ChIP-seq data. Several metrics have been
used in ChIP-seq studies to tackle this challenge, including
motif enrichment, ChIP-qPCR, benchmark of peaks, TF
knockdown with small interfering RNA (siRNA) or short
hairpin RNA (shRNA) followed by RNA-seq profiling, en-
richment of histonemodification ormethylation signals and
functional enrichment of target genes. In this study, we com-
pared the results of different peak calling methods on vali-
dated benchmark of peaks, target genes identified through
TF knockdown with shRNA followed by RNA-seq profil-
ing and enrichment of histone modification for active pro-
moters.
Benchmarks of three TFs, MAX, NRSF and SRF, have
been manually curated by Rye et al. (28) using their ChIP-
seq data.We downloaded the ChIP-seq data and the bench-
marks of MAX, NRSF and SRF (28). All peak calling
methods were run with default or recommended settings for
TFBS identification. For each TF, using results of PeakSeq
we calculated the proportion of peaks within gene promoter
regions among peaks detected from the whole genome, as
shown in Supplementary Material S8, Supplementary Fig-
ure S16. For these three TFs, on average ∼50% of peaks
are located at gene promoter regions. Then, we performed
a filtering step on both benchmarks and identified peaks of
each method using gene promoter regions for a fair com-
parison between ChIP-BIT and competing methods. Num-
bers of filtered benchmark regions and peaks are summa-
rized in Supplementary Material S8, Supplementary Tables
S6 and S7. For each TF, read intensities of peaks identified
by ChIP-BIT in sample or input data are shown in Supple-
mentary Material S8, Figures S17–S19. Furthermore, the
rates of false positives (peaks overlapping with ‘negative’ re-
gions), calculated according to the definition in (28) each
time a new true positive (peak overlapping with a ‘posi-
tive’ region) is encountered, are shown in Figure 4A–C, for
MAX, NRSF and SRF, respectively. As we can see from
Figure 4A, all the methods worked well with a very similar
performance in detecting peaks of MAX in promoter re-
gions. As shown in Figure 4B, ChIP-BIT had a significantly
lower false positive rate than others on detecting proximal
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Figure 4. Performance comparison using real ChIP-seq data. (A) False positive rate of K562 MAX peaks; (B) False positive rate of K562 NRSF peaks;
(C) False positive rate of Gm12878 SRF peaks; (D) Average overlap of RNA-seq validated target genes of each method; (E) Overlap rate of promoter
bound peaks with H3K4me3 enriched active promoters; (F) Overlap rate of promoter bound peaks of PcG proteins with bivalent promoters enriched by
both H3K4me3 and H3K27me3.
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Table 1. Overall precision-recall performance, F-measure, on peak detection
Method ChIP-BIT MOSAiCS PeakSeq MACS BCP Dfilter
Case 1 (all peaks) 0.9045 0.8477 0.8289 0.8100 0.8076 0.7932
Case 1 (weak binding signals) 0.8318 0.7989 0.7352 0.7700 0.7493 0.7452
Case 2 (all peaks) 0.9078 0.8179 0.8398 0.8123 0.8037 0.7664
Case 2 (weak binding signals) 0.8328 0.7775 0.7084 0.7692 0.7253 0.7233
Table 2. AUC performance on target gene prediction
Method Case 1 Case 2
Promoter region Promoter region
±10k bps ±5k bps ±2k bps ±10k bps ±5k bps ±2k bps
ChIP-BIT 0.923 0.948 0.972 0.943 0.972 0.982
Ouyang 0.730 0.801 0.846 0.819 0.836 0.892
Improved TIP 0.786 0.839 0.875 0.896 0.855 0.810
TIP 0.698 0.753 0.812 0.819 0.822 0.797
peaks of NRSF. ChIP-BIT also exhibited a better perfor-
mance than most of the competing methods for proximal
peak detection of SRF (see Figure 4C).
To compare the prediction performance of different
methods in identifying target genes, we downloaded K562
cell line ATF3, EGR1 and SRF ChIP-seq data from the
ENCODE project and the matched RNA-seq data before
or after specific short hairpin RNA (shRNA) treatment for
each TF (GEO access number GSE33816). For these spe-
cific TFs, on average∼55%of peaks are identified from gene
promoter regions, as shown in Supplementary Material S8,
Supplementary Figure S20. TF-specific shRNA shall effi-
ciently lower (with at least a 70% reduction) the expression
of the protein of interest. We compared the prediction per-
formance of different methods in terms of differentially ex-
pressed downstream target genes when a specific upstream
regulator was knocked down. Detailed procedures to iden-
tify differentially expressed genes using RNA-seq data can
be found in Supplementary Material S8.2 and the heatmap
of the identified target genes can be found in Supplemen-
tary Figure S21. Specifically, we selected two peak callers,
PeakSeq and MACS, for TFBS prediction using ChIP-seq
data as they have been widely used in the ENCODEproject.
The identified peaks were annotated using GREAT (10) for
target gene prediction. TIP was also applied to each ChIP-
seq sample data to predict target genes directly. Numbers
of ChIP-seq target genes and those differentially expressed
ones are summarized in Supplementary Material S8, Sup-
plementary Tables S8–S10. It can be found that the rate
of differentially expressed genes among all ChIP-seq tar-
gets is ∼10–15%, regardless of the varying number of tar-
get genes predicted by individual method. This is consistent
to previous observations that about 14.7% of target genes
were differentially expressed following the knockdown of
a specific TF (29). However, TIP had a relatively lower
rate, indicating a higher false positive rate due to that no
ChIP-seq input data were used. Since there was no ground
truth of target genes, we compared the ‘average overlap with
other methods’ (i.e. proportion of target genes overlapped
with other methods) on those differentially expressed tar-
get genes identified by each method, as shown in Figure 4D.
We assumed that ‘true’ target genes should be differentially
expressed when its regulator was knocked down and be de-
tected more consistently using different methods. Note that
the measure of ‘average overlap with other methods’ has
been used for peak comparison among different peak call-
ing approaches when ground truth evidence is not available
(30). As shown in Figure 4D, ChIP-BIT exhibited the high-
est average overlap while TIP, using sample ChIP-seq data
only, had the lowest average overlap for all three TFs.
Finally, we investigated the enrichment of ‘active’ marker
H3K4me3 at promoter bound peaks identified by each peak
calling method. It has been demonstrated that about 91%
of all the Pol II islands are correlated with H3K4me3 is-
lands, and H3K4me3 enrichment correlates with gene ex-
pression positively (31). Therefore, H3K4me3 enrichment
can be used as a positive indicator to locate active bind-
ings at target gene promoters. We downloaded H3K4me3
enriched regions of the same cell line, K562, from the EN-
CODE project and calculated the average overlap rate (de-
fined by the number of promoter bound peaks overlapped
with H3K4me3 enrichment divided by the number of all
promoter bound peaks) of the five TFs (ATF3, EGR1,
MAX, NRSF and SRF) for each peak calling method. It
can be seen from Figure 4E that peaks identified by ChIP-
BIT had a significantly higher overlap rate with H3K4me3
enriched regions than the other methods. Hence, ChIP-BIT,
by incorporating distance-based regulatory effect on target
genes, shows its effectiveness in locating active bindings of
TFs as indicted by the H3K4me3 enrichment.
TF co-association clusters in Leukemia K562 cell line
We applied ChIP-BIT to a large-scale ChIP-seq data set
(with 117 ChIP-seq profiles of leukemia K562 cell line 17)
to demonstrate its usefulness for binding site identification.
With the binding sites identified byChIP-BIT, we then stud-
ied the co-association relationship among the 117 TFs pro-
filed. TF co-association on leukemia cell line K562 has been
investigated by the ENCODEgroup (17), whereMACS and
PeakSeq were used as the major peak calling tools. It is re-
ported that over 40%of the reported peaks are within±2.5k
bps of TSS. In this paper, for those representative TFs, 50–
60% of peaks are identified in gene promoter regions when
a larger promoter region (±10k bps from TSS) is investi-
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gated (resulting in an increase of (at least) 10% peaks iden-
tified). We applied ChIP-BIT to an updated data collec-
tion including 117 ChIP-seq data sets and selected peaks
with a probability ≥0.9 to generate a TF co-association
map by following the same strategy (17). Several cluster-
ing approaches including hierarchical clustering (32), affin-
ity propagation clustering (33) and k-means (34) were car-
ried out in our study to identify those robust TF clusters.
A TF co-association map can be found in Supplementary
Material S8.3, Supplementary Figure S22.
We compared our clustering results with the original clus-
ters (17). Six of the clusters, C1–C6, show a very high sim-
ilarity with the original clusters. Cluster C7 is a unique
one and includes SUZ12, EZH2, RNF2, CBX2 and CBX8.
These TFs are mainly members of Polycomb-group (PcG)
complex and their ChIP-seq profiles were lately added to the
ENCODE ChIP-seq data set (they were not included in the
original work). From our clustering analysis of the binding
sites, this PcG complex shows a robust and unique pattern
as its binding event occurs in leukemia cells. Therefore, all
clusters identified here are either consistent with the orig-
inal clusters reported (Cluster C1–C6) or well supported
by available biological knowledge on members of the PcG
(Cluster C7). In summary, ChIP-BIT not only can identify
TF binding sites from ChIP-seq profiles effectively, but can
it also provide reliable TF co-association pattern from large-
scale ChIP-seq profiling studies based the important bind-
ing information captured.
We also compared the peak detection results from dif-
ferent peak calling methods on the Cluster C7 consisting
of PcG proteins. PcG proteins usually serve as transcrip-
tional repressors and bind at bivalent domain to poise the
transcription of regulatory genes (35). Bivalent domain is
a particular chromatin signature at promoter region that
harbors histone modifications of both ‘repressive’ marker
H3K27me3 and ‘active’ marker H3K4me3 (36). Thus, this
signature can be used to examine PcG’s TFBSs in support
of their transcriptional regulation. We downloaded the en-
riched regions of H3K27me3 and H3K4me3 of K562 cell
line from the ENCODE project and mapped the identi-
fied peaks of each TF in Cluster C7 to bivalent promot-
ers enriched by both H3K27me3 and H3K4me3. The av-
erage overlap rate (as defined by the number of promoter
bound peaks overlapping with bivalent domain divided by
the number of all promoter bound peaks) of each method
is shown in Figure 4F. It can be seen from the figure that
ChIP-BIT showed a higher overlap rate with bivalent do-
main than that of the other competing methods.
Association between PBX1 and NOTCH3 in breast cancer
NOTCH3-mediated signaling plays an important role in the
proliferation of breast cancer cells and has emerged as a
possible therapeutic target (37). In this signaling pathway,
previously we reported that PBX1 is a target of NOTCH3 in
ovarian cancer (38). An interaction of PBX1 and NOTCH3
in breast cancer cells is implied by the correlation of their
gene expression data and the target genes identified from
PBX1 ChIP-seq data (39); NOTCH3 and PBX1 control the
expression of a large number of genes associated with en-
docrine therapy resistance in breast cancer cells. We have
acquiredNOTCH3ChIP-seq data fromMCF-7 breast can-
cer cells to further investigate the association between PBX1
and NOTCH3. The raw distributions of read intensity and
relative distance to TSS for NOTCH3 or PBX1 can be
found in Supplementary Material S9, Supplementary Fig-
ure S23. Most binding sites of PBX1 are located quite close
to the TSS, while binding sites of NOTCH3 are distributed
more evenly across the promoter region. Additionally, the
read intensity distributions of the peaks detected by ChIP-
BIT using different thresholds can be found in Supplemen-
tary Material S9, Supplementary Table S11.
Following the procedure shown in Figure 1, we identi-
fied 2871 target genes by applying ChIP-BIT to NOTCH3
ChIP-seq data.We also applied ChIP-BIT to a PBX1ChIP-
Seq data set acquired from MCF-7 cells (39) and identi-
fied 5280 target genes in total. For comparison, we called
peaks using PeakSeq or MACS and predicted target genes
using GREAT by setting promoter regions as ±10k bps to
the TSS. TIP was applied to the sample ChIP-seq data only
to directly predict target genes. Results of peak calling and
gene identification using different methods can be found in
SupplementaryMaterial S9, Supplementary Tables S12 and
S13. Since PeakSeq reports read enrichment in sample or in-
put ChIP-seq data for each detected peak, its read intensity
distributions of the detected peaks are comparatively shown
with those of ChIP-BIT for NOTCH3 or PBX1 in Figure 5.
Read intensity distributions of NOTCH3 peaks reported
by PeakSeq and ChIP-BIT are shown in Figure 5A and
B, respectively. We can see from Figure 5B that ChIP-BIT
separates binding signals from sample and input data sets
quite well. Although some peaks have relative ‘weak’ en-
richment in the NOTCH3 sample profile, their fold changes
are large enough for peak calling. The average fold change
of read enrichment between sample and input data is 6.57
for the NOTCH3 peaks identified by ChIP-BIT, which is
higher than a commonly used fold change threshold of 4.
Even though our exponential distribution assumption as-
signs higher weights to those peaks close to the TSS, as
shown in Figure 5C, some relatively distant peaks can still
be detected if their enrichment in the sample data is sig-
nificantly higher than that in input data. For PBX1, ChIP-
BIT also provides a better separation of sample and input
binding signals as well, as shown in Figure 5E. The aver-
age fold change of read enrichment between sample and in-
put data is 7.26 for the PBX1 peaks identified by ChIP-BIT,
alsomuch higher than a commonly used fold change thresh-
old of 4. By comparing Figure 5F–C, we can see that TFBS
location-wise distributions are different for different TFs.
For target gene prediction, similar to previous real data
analysis on K562 cell line, we present the average gene over-
lap rate of a particular method to the other methods in Sup-
plementary Material S9, Supplementary Table S13. ChIP-
BIT has the highest average overlap rate among all four
methods for either NOTCH3 or PBX1. Moreover, by ap-
plying functional enrichment analysis using QIAGEN’s In-
genuity Pathway Analysis (http://www.ingenuity.com) and
DAVID (http://david.abcc.ncifcrf.gov) on NOTCH3 target
genes in the NCI/Nature interaction, QIAGEN pathway
and KEGG pathway databases (links to pathway databases
can be found in Supplementary Material S10), we identi-
fied 22 Notch signaling pathway genes from the NOTCH3
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Figure 5. Peak calling results of NOTCH3 or PBX1 by using ChIP-BIT and PeakSeq. (A) Read intensities of PeakSeq detected NOTCH3 peaks in sample
data (red) and input data (gray); (B) read intensities of ChIP-BIT detected NOTCH3 peaks; (C) relative distances of ChIP-BIT detected peaks to TSS;
(D), (E) and (F) represent the same set of information obtained from PBX1 ChIP-seq data analysis as that of (A), (B) and (C).
target gene list of ChIP-BIT (P-value: 1.5e-2). For the tar-
get genes obtained by other methods (i.e. PeakSeq, MACS
and TIP), as shown in Supplementary Material S10, Sup-
plementary Table S16, the enrichment of Notch signaling
pathway is much less significant in terms of the number
of genes or the statistical significance (P-value). Further-
more, to identify target genes co-regulated by NOTCH3
and PBX1, we calculated the posterior probability for each
common target (Equation (19)), as shown in Supplemen-
tary Material S10, Supplementary Figure S24. By setting
the threshold at 0.95, in total we identified 621 NOTCH3-
PBX1 co-regulated target genes. ChIP-BIT identified target
genes regulated byNOTCH3, PBX1 or both can be found in
Supplementary Material, Supplementary Table S14. Note
that for other methods (PeakSeq, MACS and TIP), we di-
rectly took the intersection of two gene lists identified from
NOTCH3 and PBX1ChIP-Seq data as the co-regulated tar-
get genes; the number of co-regulated target genes is shown
in Supplementary Material S10, Supplementary Table S15.
It has been known that Notch and Wnt signaling path-
ways share some common functions (40) and cooperate in
breast and ovarian cancers (41,42). Both pathways are re-
lated to cancer stem cells, which are regarded as a main
source of cancer recurrence and chemo-resistance (43).
Functional enrichment analysis on ChIP-BIT identified
NOTCH3-PBX1 co-regulated target genes highlights en-
richment of the Notch signaling pathway (P-value: 1.5e-
3), including ARNT, BLOC1S1, CNTN1, DLL4, DTX4,
FIGF, HES1, HEY1, NCOA1, NOTCH4 and RBPJ,
and Wnt signaling pathway (P-value: 4.7e-2), including
CEBPD, IL6, KLF5, PIAS1, PRICKLE1, SMAD4, SOX2,
SOX9, WNT2, WNT2B and WNT4. The details of the en-
riched pathways can be found in Supplementary Material
S10, Supplementary Figures S25 and S26. However, the en-
richment of these two pathways from the target genes iden-
tified by other methods (i.e. PeakSeq, MACS and TIP) is
much lower, as shown in SupplementaryMaterial S10, Sup-
plementary Tables S17 and S18. Binding sites of NOTCH3
and PBX1 on selected co-regulated target genes identified
by ChIP-BIT are shown in Figure 6. In summary, the func-
tional enrichment of key pathways (i.e. Notch and Wnt)
from the identified targets by ChIP-BIT is more significant
than that from other competing methods.
Target gene validation using TF knockdown experiments
As an initial step to validate the ChIP-BIT identified tar-
get genes co-regulated by NOTCH3 and PBX1, we used
gene expression data acquired from inhibition and knock-
down experiments of NOTCH3 and PBX1. First, we inhib-
ited Notch signaling with 1 MGSI ( -secretase inhibitor
I, EMD Chemicals, San Diego, CA, USA), a well-known
Notch signaling inhibitor (38), for 48 h; both NOTCH3
 at Im
perial College London on A
pril 29, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
PAGE 13 OF 15 Nucleic Acids Research, 2016, Vol. 44, No. 7 e65
Figure 6. Binding signals of PBX1 (blue) and NOTCH3 (red) on selected
target genes. (A) HES1, (B) RBPJ and (C) HEY1 are known key genes
in Notch signaling pathway; (D) WNT2B, (E) PIAS1 and (F) SOX9 are
known key genes in Wnt signaling pathway.
and PBX1 are inhibited by GSI. Since most ChIP-seq tar-
get genes are marginally differentially expressed (29), we
set a relatively low fold change threshold, 1.3 (0.3 in its
log2 format), for differential expression analysis. A total
of 331 (53%) of ChIP-BIT identified NOTCH3-PBX1 co-
regulated target genes are differentially expressed.More de-
tails about the differentially expressed target gene identifi-
cation can be found in Supplementary Material S11.
Second, we used small interfering RNA (siRNA) to
knockdownNOTCH3 and PBX1 specifically, since siRNAs
are more specific inhibitors of NOTCH3 and PBX1 than
the GSI. PBX1 knockdown experiment using siPBX1 was
performed previously and microarray gene expression data
were made available to us by the authors (39). In this study,
we further knocked down NOTCH3 using siNOTCH3 and
acquired gene expression data for NOTCH3-PBX1 co-
regulated target gene validation. For the knockdown exper-
iment,MCF-7 cells were transfected withNOTCH3 siRNA
for 48 h followed byWestern blotting to confirm the knock-
down efficiency as shown in Figure 7A. NOTCH3 expres-
sion was clearly inhibited with siNOTCH3 compared with
its negative control.
We then performed microarray mRNA profiling by us-
ing Illumina HumanHT-12 v4 Expression BeadChip be-
fore and after siNOTCH3 is introduced to the cells. Under
each condition, we generated two replicates. The normal-
ized mRNA expression of NOTCH3 for each siRNA sam-
ple is shown in Figure 7B. NOTCH3 expression was down
regulated significantly (P-value 9.7e-3) with siNOTCH3.
Figure 7. TF knockdown experiments for target gene validation. (A)West-
ern blot of NOTCH3 protein expression after transfecting MCF-7 breast
cancer cells with siRNA ofNOTCH3 and scramble (SCR) for 48 h, includ-
ing full length (FL), transmembrane form (TM) and intracellular domain
(ICD); (B) mRNA expression levels of PBX1 andNOTCH3 across siRNA
samples; (C) mRNA expression pattern of functional PBX1-NOTCH3 co-
regulated target genes, which is shown in terms of the fold change (log2)
of expression level for each TF knockdown experiment.
Among the common genes targeted by NOTCH3-PBX1,
gene transcription can be regulated by PBX1, NOTCH3 or
both, as illustrated in Supplementary Material S11, Sup-
plementary Figure S27. Knockdown of either TF will pro-
vide a set of differentially expressed genes among 621 co-
regulated target genes, but these two sets of genes are not
necessarily the same. With a predefined fold change thresh-
old of 1.3 (0.3 in log2 format), there are 62 genes differ-
entially expressed in the siPBX1 sample, 81 genes differ-
entially expressed in the siNOTCH3 sample and 50 genes
differentially expressed in both siRNA samples. A total of
193 (30%) of target genes are differentially expressed. It is
expected that a majority of genes identified from siRNA
experiments be also differently expressed after GSI treat-
ment because GSI will inhibit both PBX1 and NOTCH3
simultaneously (as described before). After comparing to
the differentially expressed genes (331 genes) with or with-
out GSI treatment, we found 149 genes that overlapped,
as shown in Supplementary Material S11, Supplementary
Figure S28. Differentially expressed gene list under each
condition is summarized in Supplementary Material, Sup-
plementary Table S19. Functional enrichment analysis was
carried out on these 149 differentially expressed NOTCH3-
PBX1 co-regulated target genes. Notch signaling pathway
including BLOC1S1, CNTN1, HEY1, NCOA1, RBPJ and
Wnt signaling pathway including CEBPD, IL6, PIAS1,
PRICKLE1, SOX2, SOX9 are enriched with P-values of
6.7e-4 and 3.2e-3, respectively. Fold changes (before and af-
ter siRNA transfection) of these functional target genes’
expression are presented in Figure 7C, where other co-
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regulated target genes involved in these two pathways (iden-
tified from previous section) are also listed, although their
gene expression changes are less significant.
In summary, with our ChIP-seq profiling study, we have
shown that both Notch and Wnt signaling pathways are
enriched among functional target genes co-regulated by
NOTCH3 and PBX1. While further biological validation
experiments are likely needed, our computational analysis
supports the hypothesis that crosstalk between these two
pathways may exist downstream of transcription factors
PBX1 andNOTCH3. The existence of such crosstalk would
require further experiments for biological validation so as to
establish the association of Notch and Wnt signaling path-
ways with the development and progression of breast can-
cer.
DISCUSSION
In this paper, a Bayesian approach, ChIP-BIT, was devel-
oped and applied to identify ChIP-seq binding peaks and
their target genes. While there are a few peak calling tools
like PeakSeq or MACS available for ChIP-seq data analy-
sis, by using the same peak annotation tool as GREAT it
appears that the target genes they report are different. Dif-
ferences in input-sample data normalization, background
region filtering, wide peak partition, mathematical models
and thresholds for peak selection likely explain the final dif-
ferences in target gene identification. Our objective was to
identify ChIP-Seq peaks and target genes simultaneously
using an integrative approach rather than taking multiple
independent steps.
In contrast to conventional peak detection methods,
ChIP-BIT will compute a probability for each peak re-
ported rather than a significance P-value. All peaks are
modeled with a global probabilistic model so that proba-
bilities of different peaks are directly comparable. Strong or
weak binding signals are defined according to their read in-
tensities in the sample ChIP-seq data.Weak binding regions
have an overall lower read intensity in the sample ChIP-seq
data but as TF specific binding sites, compared to the low lo-
cal input signal, their fold changes are still significant. Such
weak binding signals can be used in any post-processing
step by incorporating their probabilities of binding occur-
rences. In addition, ChIP-BIT predicts TFBSs and target
genes simultaneously, where each TFBS has been assigned
to a target gene. As a straightforward extension, for a pair
of TFs, their co-regulated target genes can be called based
on the probabilities reported by ChIP-BIT. Rather than us-
ing peak overlap or gene overlap, we model each co-binding
event using the probability for each binding and their rela-
tive distance at gene’s promoter region. Finally, ChIP-BIT
assigns each common target gene a probability indicating
the co-regulation strength of both TFs.
The method is applied to identify peaks that lay in pro-
moter regions around TSSs, whose results can be easily inte-
grated with gene expression data for functional target gene
identification or gene regulatory network inference. Those
target genes with a high probability can be validated by us-
ingChIP-qPCR to show the existence of specific TFbinding
signals at their promoter region. In addition, genes identi-
fied from cell line studies can be further investigated among
tumor samples acquired from patients. However, due to the
limited scale of the promoter region (±10k) and sharp peak
preference, the proposed method cannot be directly applied
to identify distant enhancers or broad histone modifica-
tions. As enhancers or histone modifications may be lo-
cated quite distant from a gene’s TSS, or cover the whole
gene body, these are usually investigated without an empha-
sis on target gene association. To address this problem, we
will modify the ChIP-BIT algorithm in the future to find an
alternative solution to distance-free enriched region detec-
tion.
In summary, to identify target genes associated with TF-
BSs, we have developed a probabilistic method called ChIP-
BIT to identify ChIP-seq enriched peaks. Each peak is an-
notated by a target gene and more importantly, has a prob-
ability reflecting its binding strength. ChIP-BIT is a novel
Bayesian approach in that (i) a Gaussian mixture model is
developed to help improveweak binding event detection; (ii)
an exponential distribution is incorporated to model the ef-
fect of TFBSs on their target gene transcription. Through
simulation studies, we have demonstrated that ChIP-BIT
distinguishes enriched peaks especially those weak ones
from background signals better than most available tools.
By using ChIP-BIT to identify target genes co-regulated
by both PBX1 and NOTCH3 in MCF-7 cells, we have
found that there is a significant interaction between PBX1
and NOTCH3 on target gene regulation. Functional en-
richment analysis in breast cancer cells supports crosstalk
between the Wnt signaling and Notch signaling pathways
downstream of PBX1 and NOTCH3.
AVAILABILITY
MATLAB and R scripts of ChIP-BIT are made available to
the research community, which can be downloaded at http:
//www.cbil.ece.vt.edu/software.htm.
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